Navigation Links
Gene mutation identified for inherited pain syndrome

Researchers have identified the single mutation of the gene involved in causing// the condition of inherited pain syndrome or primary erythromelalgia.

Investigators from Yale School of Medicine have reported in their research findings that the single mutation of the gene for sodium channel Nav1.7 is responsible for people to suffer from the chronic condition of primary erythromelalgia. Researchers have studied the DNA samples from 36 members of a same family in which 17 members suffer from the condition. The genetic mutation makes the pain sensing neurons to be hyper excited and trigger rapids signals even at lower than normal stimulating sensations.

Primary erythromelalgia is a disorder where the symptoms are intense burning pain felt in the hands and feet. The other symptoms of the condition are redness, sensations of heat, and swelling. Anything like standing, walking, exposure to heat may trigger an episode of sudden pain. An inherited condition, erythromelalgia may be only symptomatically treated.

Previous studies have identified two mutations in the gene coding for sodium channel Nav1.7 that is linked with erythromelalgia. The new study identifies the new mutation of the gene responsible. The identification of the mutations of the gene makes it easier to develop treatment for this condition which otherwise had no treatments.

Reference: Brain, July 2005
'"/>




Page: 1

Related medicine news :

1. Minor mutations in HIV virus
2. Genetic mutation to the fountain of youth discovered
3. Success of HIV may depend in its mutations
4. BRAC2 mutations is also linked with cancers in men
5. Familial Breast cancer without gene mutation not found to cause ovarian cancer.
6. Skin Cancer caused by mutations in a single Gene
7. H-ras gene mutation linked to Costello Syndrome
8. Autoimmune disorder caused due to mutation in cryopyrin protein
9. Uterine cancer may be associated with inherited mutations and a risk of many cancers
10. Special proteins to fight TB identified
11. A new growth factor identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... ... American Farmer proudly announces the participation of Pure Line Seeds, Inc (Pure Line ... fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , Founded in ... demand grew, the small company located in Moscow, Idaho extended its sales from Northern ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers Insurance Agency, a ... northern Virginia and DC, is announcing a cooperative charity event in conjunction with ... other disorders that lead to memory impairment. , The Insight Memory Care Center ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized autonomous ... Ethereum blockchain, has released their technical specifications . , 2017 has seen an ... systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder ...
(Date:6/27/2017)... ... 2017 , ... A January 18th article on medGadget reports that ... by the year 2024 according to a new report. The article also notes that ... titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says that ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... Fabrykiewicz Scholarship Foundation Fundraiser hygiene symposium in Mystic, CT. Covering the process and ... offered their experience in these popular periodontal procedures. Drs. Toback and Urbanski practice ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... HORSHAM, Pa. , June 19, 2017  Researchers ... announced today that they will host a live, complimentary ... Perspectives from the benchtop to the real world" on ... PM EDT. This webinar will feature ... a rare look into the manipulation techniques abusers use ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: